Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Nektar Therapeutics
Scientific Title
A Phase 1/2, Open-Label, Multicenter Study to Investigate the Safety and Preliminary Efficacy of NKTR-214 in Combination With Pembrolizumab in Patients With Locally Advanced or Metastatic Solid Tumors